SCHEMBL30908473

SCHEMBL30908473

COc1ccc(CN2Cc3c(cccc3[N+](=O)[O-])C2=O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 1/20 0.48
DCTPP1 Q9H773 1/20 0.48
KDM4E B2RXH2 1/20 0.45
GAA P10253 2/20 0.43
CASP3 P42574 2/20 0.43
MAPT P10636 3/20 0.43
APP P05067 2/20 0.43
SNCA P37840 2/20 0.43
MEN1 O00255 1/20 0.43
APAF1 O14727 1/20 0.43
KMT2A Q03164 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
CHRM5 P08912 1/20 0.43
MAOA P21397 1/20 0.42
POLB P06746 1/20 0.42
KCNJ1 P48048 1/20 0.42
KCNH2 Q12809 1/20 0.42
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14348206 0.85 DHPS (0.54) IDH1KDM4ECASP3MAPTAPP
SCHEMBL31281346 0.81 DCTPP1 (0.48) DCTPP1GAACASP3MEN1APAF1
SCHEMBL31159232 0.81 IDH1 (0.52) IDH1KDM4EGAACASP3MEN1
SCHEMBL29506999 0.81 IDH1 (0.52) IDH1KDM4EGAACASP3MEN1
SCHEMBL30908544 0.81 IDH1 (0.52) IDH1KDM4EGAACASP3MAPT
SCHEMBL25337041 0.81 IDH1 (0.52) IDH1KDM4EGAACASP3MEN1
SCHEMBL19582251 0.80 DCTPP1 (0.45) DCTPP1KDM4EGAACASP3MEN1
SCHEMBL1948769 0.79 S100A4 (0.42) IDH1GAAMAPTMEN1KMT2A
SCHEMBL9933768 0.78 IDH1 (0.45) IDH1KDM4EMAPTMEN1KMT2A
SCHEMBL3381771 0.78 DHPS (0.41) CASP3MAPTMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720060-A1 PRMT5 INHIBITORS Ryvu Therapeutics S.A. (PL) 2026-04-08 EP disclosed
WO-2024240894-A1 PRMT5 INHIBITORS Ryvu Therapeutics S.A. (PL) 2024-11-28 WO disclosed
WO-2024074611-A1 PRMT5 INHIBITORS Ryvu Therapeutics S.A. (PL) 2024-04-11 WO disclosed